Back to
Avoro Capital Advisors LLC
TGTX
3 quarters
Position history for
Avoro Capital Advisors LLC's holdings in TG Therapeutics, Inc.
No. Avoro Capital Advisors exited its TGTX (TG Therapeutics) position in Q2 2020. Its Q1 2020 13F listed 800,000 shares worth $7.9M. Avoro Capital Advisors first reported TGTX in Q4 2019 and held it in 2 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$11.1M
Total Shares Change
-1M
Quarter-by-Quarter History
Other major holders of TGTX: BlackRock, Inc., FMR LLC